NCT04322955 2025-04-25
Cyto-KIK
Columbia University
Phase 2 Recruiting
Clinical Trials
5 trialsNCT03634540 2024-12-20
MK-6482-003
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2 Active not recruiting
NCT03428217 2023-03-20
CANTATA
Calithera Biosciences, Inc
Phase 2 Completed
NCT01688999 2022-10-18
Cabozantinib for Advanced Urothelial Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT05241561 2022-06-01
Cabo-POLARIS
Centre Hospitalier Universitaire de Besancon
Phase 2 Not yet recruiting